7.93

1.28% 0.10

Aurinia Pharmaceuticals Inc (AUPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AUPH? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$7.83

Offen:

$7.92

24-Stunden-Volumen:

1.10M

Relative Volume:

0.85

Marktkapitalisierung:

$1.14B

Einnahmen:

$175.51M

Nettoeinkommen (Verlust:

$-78.02M

KGV:

-14.96

EPS:

-0.53

Netto-Cashflow:

$-34.18M

1W Leistung:

+1.80%

1M Leistung:

+2.59%

6M Leistung:

+20.33%

1J Leistung:

+38.15%

1-Tages-Spanne:

$7.785

$7.96

1-Wochen-Bereich:

$7.502

$8.095

52-Wochen-Spanne:

$4.71

$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Firmenname

Aurinia Pharmaceuticals Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

250-744-2487

Adresse

#140, 14315 - 118 AVENUE, EDMONTON, BC

Mitarbeiter

300

Twitter

@AuriniaPharma

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

AUPH's Discussions on Twitter

Vergleichen Sie AUPH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AUPH Aurinia Pharmaceuticals Inc	7.93	1.14B	175.51M	-78.02M	-34.18M	-0.53
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-11-04	Herabstufung	Oppenheimer	Outperform → Perform
2022-05-05	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-12-10	Hochstufung	Oppenheimer	Perform → Outperform
2021-10-28	Herabstufung	Oppenheimer	Outperform → Perform
2021-01-25	Bestätigt	H.C. Wainwright	Buy
2020-11-03	Bestätigt	H.C. Wainwright	Buy
2020-06-17	Eingeleitet	BTIG Research	Buy
2020-05-05	Eingeleitet	Cowen	Outperform
2020-01-10	Eingeleitet	Jefferies	Buy
2019-12-16	Bestätigt	H.C. Wainwright	Buy
2018-03-16	Bestätigt	Cantor Fitzgerald	Overweight
2018-02-08	Eingeleitet	RBC Capital Mkts	Outperform
2017-10-30	Bestätigt	H.C. Wainwright	Buy
2017-05-18	Bestätigt	H.C. Wainwright	Buy
2017-04-11	Eingeleitet	Cantor Fitzgerald	Overweight
2017-03-22	Bestätigt	FBR & Co.	Outperform
2016-12-30	Bestätigt	H.C. Wainwright	Buy
2016-08-17	Bestätigt	H.C. Wainwright	Buy
2016-06-30	Eingeleitet	H.C. Wainwright	Buy
2015-05-08	Eingeleitet	MLV & Co	Buy

Alle ansehen

Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten

Feb 21, 2025

(AUPH) On The My Stocks Page - Stock Traders Daily

Feb 21, 2025

Aurinia Pharmaceuticals: There's Still Time For Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Feb 21, 2025

Feb 20, 2025

Aurinia Pharmaceuticals (AUPH) to Release Earnings on Thursday - MarketBeat

Feb 20, 2025

When Will Aurinia Report Q4 Earnings? Key Date and Details for Investors - StockTitan

Feb 20, 2025

Feb 19, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Lowered to Buy at StockNews.com - MarketBeat

Feb 19, 2025

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - Simply Wall St

Feb 19, 2025

Compagnie Lombard Odier SCmA Cuts Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Feb 19, 2025

Short Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Grows By 25.5% - MarketBeat

Feb 19, 2025

Feb 18, 2025

Aurinia (AUPH) Upgraded to Buy: Here's Why - MSN

Feb 18, 2025

Head-To-Head Analysis: Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. XBiotech (NASDAQ:XBIT) - Defense World

Feb 18, 2025

Feb 16, 2025

Aurinia Pharmaceuticals (AUPH) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 16, 2025

Feb 14, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by StockNews.com to Buy - MarketBeat

Feb 14, 2025

Feb 13, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat

Feb 13, 2025

Aurinia Pharmaceuticals (AUPH) to Release Quarterly Earnings on Thursday - Defense World

Feb 13, 2025

Feb 11, 2025

Perhaps timely catching Aurinia Pharmaceuticals Inc (AUPH) would be a good idea - SETE News

Feb 11, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Buy Rating by StockNews.com - Defense World

Feb 11, 2025

Objective long/short (AUPH) Report - Stock Traders Daily

Feb 11, 2025

Feb 10, 2025

A Guide To The Risks Of Investing In Aurinia Pharmaceuticals Inc (AUPH) - Knox Daily

Feb 10, 2025

Feb 07, 2025